Using Positron Emission Tomography and Carbon 11-Labeled Pittsburgh Compound B to Image Brain Fibrillar {beta}-Amyloid in Adults With Down Syndrome: Safety, Acceptability, and Feasibility
Landt et al.
Arch Neurol 2011;68:890-896.
ABSTRACT
| FULL TEXT
Alzheimer's Disease: The Challenge of the Second Century
Holtzman et al.
Sci Transl Med 2011;3:77sr1-77sr1.
FULL TEXT
Compliance Training in an Adult With Dementia of the Alzheimer's Type and Down Syndrome
Horovitz et al.
Clinical Case Studies 2010;9:207-217.
ABSTRACT
Compliance Training in an Adult With Dementia of the Alzheimer's Type and Down Syndrome
Horovitz et al.
Clinical Case Studies 2010;9:95-105.
ABSTRACT
Down syndrome--recent progress and future prospects
Wiseman et al.
Hum Mol Genet 2009;18:R75-R83.
ABSTRACT
| FULL TEXT
Epilepsy and Cognitive Impairments in Alzheimer Disease
Palop and Mucke
Arch Neurol 2009;66:435-440.
ABSTRACT
| FULL TEXT
Elevated Plasma beta-Amyloid Peptide Abeta42 Levels, Incident Dementia, and Mortality in Down Syndrome
Schupf et al.
Arch Neurol 2007;64:1007-1013.
ABSTRACT
| FULL TEXT
The subjective experience of individuals with Down syndrome living with dementia
Lloyd et al.
Dementia 2007;6:63-88.
ABSTRACT
Phenotype associated with APP duplication in five families
Cabrejo et al.
Brain 2006;129:2966-2976.
ABSTRACT
| FULL TEXT
Alzheimer's dementia in persons with Down's syndrome: Predicting time spent on day-to-day caregiving
McCarron et al.
Dementia 2005;4:521-538.
ABSTRACT
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry
Teipel et al.
Brain 2004;127:811-824.
ABSTRACT
| FULL TEXT
Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia
Haier et al.
Neurology 2003;61:1673-1679.
ABSTRACT
| FULL TEXT
Why Wait for Dementia?
Watchman
J Intellect Disabil 2003;7:221-230.
ABSTRACT
Screening for Dementia in Primary Care: A Summary of the Evidence for the U.S. Preventive Services Task Force
Boustani et al.
ANN INTERN MED 2003;138:927-937.
ABSTRACT
| FULL TEXT
Adverse effects of phenytoin given for late-onset seizures in adults with Down syndrome
Tsiouris et al.
Neurology 2002;59:779-780.
FULL TEXT
Genetic and host factors for dementia in Down's syndrome
SCHUPF and Sergievsky
Br. J. Psychiatry 2002;180:405-410.
ABSTRACT
| FULL TEXT
APOE {epsilon}4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome
DEB et al.
Br. J. Psychiatry 2000;176:468-472.
ABSTRACT
| FULL TEXT
APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome
Lai et al.
Neurology 1999;53:331-331.
ABSTRACT
| FULL TEXT
The Role of Magnetic Resonance Imaging in the Diagnosis of Alzheimer Disease in Adults With Down Syndrome
Prasher et al.
Arch Neurol 1996;53:1310-1313.
ABSTRACT
Neuropathological Changes in Down's Syndrome Hippocampal Formation: Effect of Age and Apolipoprotein E Genotype
Hyman et al.
Arch Neurol 1995;52:373-378.
ABSTRACT
Age-Related Distribution of Neuropathologic Changes in the Cerebral Cortex of Patients With Down's Syndrome: Quantitative Regional Analysis and Comparison With Alzheimer's Disease
Hof et al.
Arch Neurol 1995;52:379-391.
ABSTRACT
